(Q34809311)

4 August 2017

1 reference

title

Lowering plasma homocysteine with folic acid in cardiovascular disease: what will the trials tell us? (English)

1 reference

4 August 2017

main subject

cardiovascular disease

1 reference

1 reference

2

Stuart J Moat

1 reference

4 August 2017

5

Jonathan Goodfellow

1 reference

4 August 2017

Sagar N Doshi

1

1 reference

4 August 2017

Ian F W McDowell

series ordinal

3

1 reference

4 August 2017

Malcolm J Lewis

series ordinal

4

1 reference

4 August 2017

publication date

1 November 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

165

1 reference

4 August 2017

issue

1

1 reference

4 August 2017

page(s)

1-3

1 reference

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900191-0

Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900191-0

Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900191-0

Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900191-0

Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900191-0

Folic acid--an innocuous means to reduce plasma homocysteine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900191-0

Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900191-0

The pathogenesis of atherosclerosis: a perspective for the 1990s

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900191-0

Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900191-0

Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900191-0

Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900191-0

Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900191-0

Improving endothelial vasomotor function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900191-0

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900191-0

Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900191-0

Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900191-0

Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900191-0

Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900191-0

5-Methyltetrahydrofolate, the Active Form of Folic Acid, Restores Endothelial Function in Familial Hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900191-0

Folic Acid Reverts Dysfunction of Endothelial Nitric Oxide Synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900191-0

10.1016/S0021-9150(02)00191-0

7 January 2021

Identifiers

DOI

1 reference

release_vr5lce653jck7g6cqvf4yl7lzu

4 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vr5lce653jck7g6cqvf4yl7lzu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference